Natasha Baldev Hirani, DO, MPH
Medical Oncology Physician · Houston, TX
Natasha Baldev Hirani, DO, MPH is a medical oncology physician with a practice address in Houston, Texas, and NPI 1659715357, issued on Apr 24, 2013. Check the license (Texas R7225, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Natasha Baldev Hirani
- Credential
- DO, MPH
- Primary taxonomy
- Medical Oncology Physician 207RX0202X
- License number
- R7225 TX
Self-reported in NPPES; status is on the state search - Practice location
- 18100 Houston Methodist Dr Ste 300, Houston, TX 77058
- Phone
- (832) 783-1190
- Enumerated
- Apr 24, 2013
- Record last updated
- Aug 24, 2021 (not updated in 5 years: call before relying on the address or phone)
- Fax
- (281) 333-0180
- Medicare enrollment
- Enrolled (PECOS I20210831002062); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest medical oncology physician records → All 547 in Texas → Look up another NPI →
Also registered at 18100 Houston Methodist Dr Ste 300
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Jitesh Joshi, M.D.Hematology & Oncology Physician1679737969
- Michelino Scarlata, M.D.Surgery Physician1508096413
Verify Natasha Baldev Hirani in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license R7225Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
32% more Medicare Part D claims than the average medical oncology physician in 2024
929 Medicare Part D claims for 192 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. 65 claims were for opioids.
Most prescribed
- Anastrozole100 claims
- Tamoxifen Citrate79 claims
- Letrozole69 claims
- Prochlorperazine Maleate68 claims
- Ondansetron Odt65 claims
- Prednisone53 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $277.61
9 payments; by number, the most common kind was food and beverage; the largest payer was Astellas Pharma US Inc. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through 2 group practices
- Houston Methodist Specialty PhysiciansHouston, TX
- Tmh Physician Associates PLLCSugar Land, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Natasha Baldev Hirani among 547 medical oncology physician records in Texas
Natasha Baldev Hirani, DO, MPH is one of 547 medical oncology physician records with a practice address in Texas. 85% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2013, is newer than 85% of them.
- NPI issued2013 · 85% of these records are older, 13% newer
- In a Medicare fileYes · 85% of these records are
- In the CMS Doctors and Clinicians fileYes · 76% of these records are
- Graduated2013 · median 2000 among the 414 with a school on file
- Record last updated2021 · 62% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RX0202X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Medical Oncology Physician providers in Texas
There are 547 medical oncology physician records in Texas.
All 547 in Texas → Every provider in Houston → Medical Oncology Physician nationwide →
The 8 medical oncology physician records with the nearest ZIP codes
- Amir Salam, M.D.Houston, TX 770581346569316
- Robert Weaver, M.D.Houston, TX 770551720395064
- Peter Demaria, M.D.Houston, TX 770541811230873
- Vipal Durkal, MDHouston, TX 770541376962795
- Aparna Jotwani, MDHouston, TX 770541497838320
- Demetria Smith-Graziani, M.D.Houston, TX 770541639565591
- Haris Zahoor, MDHouston, TX 770541700017217
- Yuqi ZhangHouston, TX 770541124656152
Common questions
What is Natasha Baldev Hirani, DO, MPH's NPI number?
Natasha Baldev Hirani, DO, MPH's National Provider Identifier (NPI) is 1659715357, issued on Apr 24, 2013. An NPI identifies a provider in billing; it is not a license.
Where is Natasha Baldev Hirani, DO, MPH located?
The NPPES record lists a practice address at 18100 Houston Methodist Dr Ste 300, Houston, TX, 77058. Phone: (832) 783-1190. Providers update this record themselves, so call before visiting.
How can I verify Natasha Baldev Hirani, DO, MPH's license?
NPPES lists Texas license number R7225, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Natasha Baldev Hirani, DO, MPH prescribe under Medicare Part D?
In 2024, Natasha Baldev Hirani, DO, MPH had 929 Medicare Part D claims for 192 beneficiaries; the average among medical oncology physician prescribers was 703. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.